Add-on interventions for the prevention of recurrent Clostridioides Difficile infection: A systematic review and network meta-analysis

CONCLUSION: Add-on treatment with oligofructose, NTCD-M3 spores, rifaximin, RBX2660, and bezlotoxumab likely reduces the risk of CDI. Evidence on probiotics and SER-109 are uncertain, thus adequately powered trials are warranted.PMID:34454094 | DOI:10.1016/j.anaerobe.2021.102441

Source: Anaerobe - August 28, 2021 Category: Microbiology Authors: Paschalis Paschos Konstantinos Ioakim Konstantinos Malandris Argyro Koukoufiki Tarek Nayfeh Evangelos Akriviadis Apostolos Tsapas Eleni Bekiari Source Type: research